The diagnosis of cirrhosis has experienced important progresses in recent years. In addition to improved techniques for a good diagnose, this diagnosis is now richer in information about patient’s prognosis and the degree of development of pathology. Dr. Guadalupe Garcia-Tsao, from Yale University, spoke about it at a recent IDIBAPS seminar, held on Monday January 23. She is a regular collaborator of the team led by Dr. Jaume Bosch at IDIBAPS - Hospital Clínic, an international reference in the field of hepatology and liver hemodynamics.
Thursday January 26th, 2012
The last IDIBAPS seminar focused on the advancement in cirrhosis classification
No Comments
Thursday January 26th, 2012
A multimedia application for schools to learn about biomedicine and how does a laboratory work
Multimedia applications are an ideal tool to stimulate learning and explaining complex concepts. That is the reason Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), the biomedical research center linked to the Hospital Clínic of Barcelona, the University of Barcelona and the CSIC, joined efforts with Ambientech, an institution specialized in educational portals. The result is a virtual laboratory designed to become an educational support in the classrooms, which explains scientific concepts and explains everyday activity in clinical and basic laboratories. This activity, which was started with a grant from the Generalitat de Catalunya (ACDC 2010) and had the support of the Obra Social “la Caixa”, is now available in Spanish, Catalan e English and at www.ambientech.org.
Tuesday January 24th, 2012
The meetinc Challenges and risks of Research on Advanced Therapies brings together more than a hundred scientists, companies and professionals
The technical conference Challenges and Risks of Research on Advanced Therapies brings together more than a hundred scientists, companies and professionals to analyze the current status and future prospects of research in advanced therapies. The meeting, held on Friday January 20 in the IDIBAPS ‘ CEK building and jointly organized by Biocat and the Cell Therapy Program (TCUB) of the UB Faculty of Medicine, is part of the thematic meetings organized periodically by Biocat to discuss on emerging scientific and technological topics of interest.
Tuesday January 24th, 2012
Histocell will develop a cell therapy against lung fibrosis based on a patent from the CSIC and the Hospital Clínic
Histocell, Hospital Clínic de Barcelona and the Higher Council for Scientific Research (CSIC) have signed a licensing agreement by which the Basque biotech will invest a minimum of three million Euros and its industrial capacity for the next three years to move forward the development of drugs against idiopathic pulmonary fibrosis. Genoma España, through Innocash program, will provide 450,000 additional Euros to the company through a financing loan. The team that develops the therapeutic approach that could become the first treatment for idiopathic pulmonary fibrosis is headed by Dr. Ana Serrano, IIBB-CSIC researcher, and Dr. Antoni Xaubet, medical researcher at the Hospital Clínic - IDIBAPS.
Information via Biocat.
Friday January 20th, 2012
Can dogs detect hypoglycaemia and assist a patient during one of these episodes?
Hypoglycaemia (a fall of blood sugar in the blood) may develop within minutes in people with type 1 diabetes. It is usually preceded by symptoms such as sweating, nervousness, or palpitations. There is no efficient system to prevent hypoglycaemia, which may occur at home during the night. British researchers have discovered that dogs often show an altered behaviour when a crisis of hypoglycaemia is about to occur to one of his owners. Amicus Canis is a research project led by CIBER of Diabetes and Associated Metabolic Disorders (CIBERDEM) investigating what does detect the dog and educating it to do so, integrating thus the animal into the family life of the patient. This study was performed in collaboration with the l’Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - Hospital Clínic, Universitat Autònoma de Barcelona, Argus Detection Dogs and the Associació de Diabètics de Catalunya.
More information about Amicus Canis: www.investigaladiabetes.org
Wednesday January 18th, 2012
IDIBAPS joins an ambitious project to find a cure for Huntington’s disease
By now Huntington’s disease has no effective treatment, and there are no appropriate experimental models to study potential drugs. The Cure of Huntington’s Disease Initiative (CHDI) is promoting an international effort to change this. This is a private foundation that was interested in embryonic stem cell work by the Stem cells and regenerative medicine group led by Dr. Josep M. Canals, from the IDIBAPS team of Cellular biology of pathological processes and the Department of Cell Biology, Immunology and Neuroscience of the University of Barcelona’s Faculty of Medicine.
